AAGH — America Great Health Income Statement
0.000.00%
Last trade - 00:00
- $59.33m
- $61.04m
- $0.20m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.005 | 0.196 | 0.105 | 0.204 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.002 | 0.051 | -1.48 | 0.169 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 0.047 | 0.052 | 0.439 | 4.84 | 0.697 |
Operating Profit | -0.047 | -0.046 | -0.244 | -4.73 | -0.493 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.064 | -0.051 | -0.269 | -4.92 | -0.777 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.065 | -0.052 | -0.269 | -4.92 | -0.777 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.065 | -0.052 | -0.269 | -4.87 | -0.761 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.065 | -0.052 | -0.269 | -4.87 | -0.761 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | 0 | -0 | -0 | -0 |